Dr Chris Schilling is an academic and consultant health economist who has over 15 years of experience in economic modelling and research across academia, industry, and consultancy. As part of the NHMRC Centre for Research Excellence in Total Joint Replacement, Dr Schilling conducts research into the cost-effectiveness of surgery and the reduction of low-value care in the treatment of osteoarthritis. Dr Schilling also leads the KPMG health economic team, where he and his team provide economic evaluation and modelling to a range of government and industry clients with work that has influenced key public policy debates around obesity, mental health, low-value care, and e-cigarettes.